Pomytkina N V, Sorokin E L
Khabarovsk branch of S. Fyodorov Eye Microsurgery Federal State Institution, 211 Tikhookeanskaia St., Khabarovsk, Russian Federation, 680033.
Khabarovsk branch of S. Fyodorov Eye Microsurgery Federal State Institution, 211 Tikhookeanskaia St., Khabarovsk, Russian Federation, 680033; Far-Eastern State Medical University, 35 Muravyov-Amursky St., Khabarovsk, Russian Federation, 680000.
Vestn Oftalmol. 2019;135(3):55-66. doi: 10.17116/oftalma201913503155.
Pregnancy is a risk factor for progression of diabetic retinopathy (DR). Despite the common opinion about the regression of DR after childbirth, it is possible for the disease to progress aggressively, which can cause loss of visual functions when treated untimely.
To present clinical cases with different course of development of DR in pregnant women with type 1 diabetes mellitus (DM1).
Five pregnant women with DM1 lasting more than 8 years were examined. Glycemic level of all patients was higher than normal (glycated hemoglobin (HbA1c) of more than 6.1%). Ophthalmologic examination was carried out including fundus photography, optical coherence tomography (OCT) of the macular area, Angio-OCT.
The most significant factors in the progression of DR in pregnant women are DR1 compensation, severity and stabilization of DR during the preconception period, presence of a concomitant pathology. Timely detection of signs of progression of DR and therapeutic measures taken during pregnancy, in particular laser coagulation, were shown to stabilize the course of the disease and prevent loss of vision in pregnant women with DM1.
Clinical course of DR in pregnancy can vary between absence of manifestation, stabilization, and progression. Progression of DR during pregnancy is determined by a number of factors including compensation of DM during the preconception period and throughout pregnancy, severity and stabilization of retinopathy during the preconception period, and presence of a concomitant pathology. Timely detection of the signs of DR progression and its treatment, in particular laser coagulation of the retina, can help stabilize the course of the disease during pregnancy. The course of DR may be aggressive in some pregnant women involving progression in the postpartum period, which warrants active monitoring of patients with retinopathy after childbirth.
妊娠是糖尿病视网膜病变(DR)进展的一个危险因素。尽管人们普遍认为产后DR会消退,但该疾病仍有可能迅速进展,如果不及时治疗,可能会导致视力丧失。
介绍1型糖尿病(DM1)孕妇中DR不同发展过程的临床病例。
检查了5例病程超过8年的DM1孕妇。所有患者的血糖水平均高于正常(糖化血红蛋白(HbA1c)超过6.1%)。进行了眼科检查,包括眼底摄影、黄斑区光学相干断层扫描(OCT)、血管OCT。
孕妇DR进展的最重要因素是DR1代偿情况、孕前DR的严重程度和稳定性、是否存在合并症。及时发现DR进展迹象并在孕期采取治疗措施,特别是激光凝固治疗,已被证明可稳定疾病进程,防止DM1孕妇视力丧失。
孕期DR的临床过程可能表现为无明显症状、病情稳定或进展。孕期DR的进展取决于多种因素,包括孕前及整个孕期DM的代偿情况、孕前视网膜病变的严重程度和稳定性以及是否存在合并症。及时发现DR进展迹象并进行治疗,特别是视网膜激光凝固治疗,有助于在孕期稳定疾病进程。在一些孕妇中,DR的病程可能较为凶险,包括产后病情进展,这就需要对产后患有视网膜病变的患者进行积极监测。